BioCentury
ARTICLE | Company News

Arachnova Therapeutics Ltd., Sosei Co. Ltd. deal

March 1, 2004 8:00 AM UTC

Sosei obtained exclusive worldwide rights from Arachnova to develop and market AA10020/SOU001 for stress urinary incontinence (SUI). Arachnova will receive an upfront license fee and is eligible for m...